About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 507216, 8 pages
http://dx.doi.org/10.1155/2013/507216
Clinical Study

Cardiovascular Autonomic Neuropathy in Context of Other Complications of Type 2 Diabetes Mellitus

1Department of Neurology, University of Medicine and Pharmacy Târgu Mureş, Târgu Mureş, Gheorghe Marinescu, No. 38, 540139, Romania
2Mureş County Clinical Emergency Hospital, Târgu Mureş, Gheorghe Marinescu, No. 50, 540136, Romania
3Department of Epidemiology, University of Medicine and Pharmacy Târgu Mureş, Târgu Mureş, Gheorghe Marinescu, No. 38, 540139, Romania

Received 24 April 2013; Revised 20 September 2013; Accepted 4 October 2013

Academic Editor: Eberval G. Figueiredo

Copyright © 2013 Anca Moţăţăianu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. I. Vinik, R. E. Maser, B. D. Mitchell, and R. Freeman, “Diabetic autonomic neuropathy,” Diabetes Care, vol. 26, no. 5, pp. 1553–1579, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. R. E. Maser and M. J. Lenhard, “Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 10, pp. 5896–5903, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. R. E. Maser, B. D. Mitchell, A. I. Vinik, and R. Freeman, “The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes a meta-analysis,” Diabetes Care, vol. 26, no. 6, pp. 1895–1901, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Tesfaye, A. J. M. Boulton, P. J. Dyck et al., “Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments,” Diabetes Care, vol. 33, no. 12, pp. 2285–2293, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Turner, “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33),” Lancet, vol. 352, no. 9131, pp. 837–853, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. I. M. Stratton, A. I. Adler, H. A. W. Neil et al., “Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study,” British Medical Journal, vol. 321, no. 7258, pp. 405–412, 2000. View at Scopus
  7. M. Wei, S. P. Gaskill, S. M. Haffner, and M. P. Stern, “Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality: the San Antonio heart study,” Diabetes Care, vol. 21, no. 7, pp. 1167–1172, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Gæde, P. Vedel, N. Larsen, G. V. H. Jensen, H. H. Parving, and O. Pedersen, “Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes,” New England Journal of Medicine, vol. 348, no. 5, pp. 383–393, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Valensi, J. Pariès, J. R. Attali et al., “Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications—the French multicenter study,” Metabolism: Clinical and Experimental, vol. 52, no. 7, pp. 815–820, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Viswanathan, D. Prasad, S. Chamukuttan, and A. Ramachandran, “High prevalence and early onset of cardiac autonomic neuropathy among South Indian Type 2 diabetic patients with nephropathy,” Diabetes Research and Clinical Practice, vol. 48, no. 3, pp. 211–216, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Spallone, D. Ziegler, R. Freeman et al., “Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management,” Diabetes/Metabolism Research and Reviews, vol. 27, no. 7, pp. 639–653, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. S. Levey, K. U. Eckardt, Y. Tsukamoto et al., “Definition and classification of chronic kidney disease: a position statement from Kidney Disease: improving Global Outcomes (KDIGO)z,” Kidney International, vol. 67, no. 6, pp. 2089–2100, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. J. W. G. Meijer, A. J. Smit, E. V. Sonderen, J. W. Groothoff, W. H. Eisma, and T. P. Links, “Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the diabetic neuropathy symptom score,” Diabetic Medicine, vol. 19, no. 11, pp. 962–965, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. C. H. Gibbons, R. Freeman, and A. Veves, “Diabetic neuropathy: a cross-sectional study of the relationships among tests of neurophysiology,” Diabetes Care, vol. 33, no. 12, pp. 2629–2634, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. American Diabetes Association American Academy of Neurology, “Consensus statement: report and recommendations of the San Antonio conference on diabetic neuropathy,” Diabetes Care, vol. 11, no. 7, pp. 592–597, 1988.
  16. J. Kimura, “Principles of nerve conduction studies,” in Electrodiagnosis in Diseases of the Nerve and Muscle: Principles and Practice, pp. 103–138, Davis, Philadelphia, Pa, USA, 1989.
  17. P. J. Dyck, “Detection, characterization, and staging of polyneuropathy: assessed in diabetics,” Muscle and Nerve, vol. 11, no. 1, pp. 21–32, 1988. View at Publisher · View at Google Scholar
  18. D. J. Ewing, C. N. Martyn, R. J. Young, and B. F. Clarke, “The value of cardiovascular autonomic function tests: 10 years experience in diabetes,” Diabetes Care, vol. 8, no. 5, pp. 491–498, 1985. View at Scopus
  19. D. Ziegler, G. Laux, K. Dannehl et al., “Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses,” Diabetic Medicine, vol. 9, no. 2, pp. 166–175, 1992. View at Scopus
  20. I. Wendelhag, T. Gustavsson, M. Suurkula, G. Berglund, and J. Wikstrand, “Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system,” Clinical Physiology, vol. 11, no. 6, pp. 565–577, 1991. View at Scopus
  21. D. Ziegler, F. A. Gries, M. Spuler et al., “The epidemiology of diabetic neuropathy,” Journal of Diabetes and Its Complications, vol. 6, no. 1, pp. 49–57, 1992. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Valensi, J. Pariès, J. R. Attali et al., “Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications—the French multicenter study,” Metabolism: Clinical and Experimental, vol. 52, no. 7, pp. 815–820, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. P. J. Dyck, J. L. Davies, D. M. Wilson, F. J. Service, L. J. Melton III, and P. C. O'Brien, “Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort,” Diabetes Care, vol. 22, no. 9, pp. 1479–1486, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Voulgari, M. Psallas, A. Kokkinos, V. Argiana, N. Katsilambros, and N. Tentolouris, “The association between cardiac autonomic neuropathy with metabolic and other factors in subjects with type 1 and type 2 diabetes,” Journal of Diabetes and its Complications, vol. 25, no. 3, pp. 159–167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. P. Töyry, J. V. S. Partanen, L. K. Niskanen, E. A. Länsimies, and M. I. J. Uusitupa, “Divergent development of autonomic and peripheral somatic neuropathies in NIDDM,” Diabetologia, vol. 40, no. 8, pp. 953–958, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Tentolouris, S. Pagoni, A. Tzonou, and N. Katsilambros, “Peripheral neuropathy does not invariably coexist with autonomic neuropathy in diabetes mellitus,” European Journal of Internal Medicine, vol. 12, no. 1, pp. 20–27, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Azad, N. V. Emanuele, C. Abraira et al., “The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM),” Journal of Diabetes and its Complications, vol. 13, no. 5-6, pp. 307–313, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. T. D. Wiggin, K. A. Sullivan, R. Pop-Busui, A. Amato, A. A. F. Sima, and E. L. Feldman, “Elevated triglycerides correlate with progression of diabetic neuropathy,” Diabetes, vol. 58, no. 7, pp. 1634–1640, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. R. H. Straub, M. Thum, C. Hollerbach, K. D. Palitzsch, and J. Schölmerich, “Impact of obesity on neuropathic late complications in NIDDM,” Diabetes Care, vol. 17, no. 11, pp. 1290–1294, 1994. View at Scopus
  30. B. Bergstrom, B. Lilja, S. Osterlin, and G. Sundkvist, “Autonomic neuropathy in non-insulin dependent (type II) diabetes mellitus. Possible influence of obesity,” Journal of Internal Medicine, vol. 227, no. 1, pp. 57–63, 1990. View at Scopus
  31. T. Laitinen, J. Lindström, J. Eriksson et al., “Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance,” Diabetic Medicine, vol. 28, no. 6, pp. 699–704, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. M. W. Lorenz, H. S. Markus, M. L. Bots, M. Rosvall, and M. Sitzer, “Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis,” Circulation, vol. 115, no. 4, pp. 459–467, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. A. R. Folsom, J. H. Eckfeldt, S. Weitzman et al., “Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity,” Stroke, vol. 25, no. 1, pp. 66–73, 1994. View at Scopus